3 hours Why Amylyx Pharmaceuticals Stock Was So Healthy This WeekThe Motley Fool
The company seems to have a winner on its hands with a drug that targets a rare genetic disorder.
Biotech · Nasdaq 100 · Pharmaceuticals
XThe company seems to have a winner on its hands with a drug that targets a rare genetic disorder.
Biotech · Nasdaq 100 · Pharmaceuticals
X